1
Jean A Setterstrom, John E Van Hamont, Robert H Reid, Elliot Jacob, Ramasubbu Jeyanthi, Edgar C Boedeker, Charles E McQueen, Daniel L Jarboe, Frederick Cassels, William Brown, Curt Thies, Thomas R Tice, F Donald Roberts, Phil Friden: Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix. The United States of America represented by the Secretary of the Army, Caroline Nash, Elizabeth Arwine, October 30, 2001: US06309669 (195 worldwide citation)

Novel burst-free, sustained release biocompatible and biodegrable microcapsules which can be programmed to release their active core for variable durations ranging from 1-100 days in an aqueous physiological environment. The microcapsules are comprised of a core of polypeptide or other biologically ...


2
Jean A Setterstrom, John E Van Hamont, Robert H Reid, Elliot Jacob, Ramasubbu Jeyanthi, Edgar C Boedeker, Charles E McQueen, Daniel L Jarboe, Frederick Cassels, William Brown, Curt Thies, Thomas R Tice, F Donald Roberts, Phil Friden: Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix. The United States of America represented by the Secretary of the Army, Elizabeth Arwine, January 18, 2005: US06844010 (5 worldwide citation)

Novel burst-free, sustained release biocompatible and biodegrable microcapsules which can be programmed to release their active core for variable durations ranging from 1-100 days in an aqueous physiological environment. The microcapsules are comprised of a core of polypeptide or other biologically ...


3
Daniel L Jarboe, Robert H Reid, Edgar C Boedeker, Frederick J Cassels: Oral-intestinal vaccines against diseases caused by enteropathic organisms using antigens encapsulated within biodegradable-biocompatible microspheres. The United States of America represented by the Secretary of the Army, Elizabeth Arwine, October 20, 2009: US07604811

This invention is directed to oral-intestinal vaccines and their use against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres.


4
Edgar C Boedeker, Frederick J Cassels, Daniel L Jarboe, Robert H Reid: Oral-intestinal vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres. Nash & Titus, March 25, 2010: US20100074913-A1

This invention is directed to oral-intestinal vaccines and their use against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres.